Over five days, the global case count of monkeypox infections rose from 16,836 to 18,095 as of July 25, according to CDC data. Out of the 75 countries that have reported monkeypox cases, the U.S. is No. 1 with 3,846 cases, which is nearly 20 percent of the world’s case count.
As the outbreak worsens and vaccine supply runs short, the Denmark-based vaccine manufacturer told Bloomberg it’s preparing to extend its operation hours and make more than its annual supply, which is 30 million doses.
The U.S. has ordered nearly 7 million doses of the company’s monkeypox vaccine, Jynneos, to arrive in batches by mid-2023. Multiple states are reporting shortages, clinics are turning people away and some cities are prioritizing the first dose in the two-shot series as they wait for more vaccines.
“We have requested 35K doses & have only received 7,800,” San Francisco’s health department tweeted July 25.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
